These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26887765)

  • 1. [Using of gonadotropin releasing hormone antagonist protocol: a committee opinion].
    Chinese Society of Reproductive Medicine, Chinese Medical Association
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):805-9. PubMed ID: 26887765
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.
    Olivennes F
    Clin Obstet Gynecol; 2006 Mar; 49(1):12-22. PubMed ID: 16456339
    [No Abstract]   [Full Text] [Related]  

  • 3. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
    Elassar A; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jun; 95(7):2330-4. PubMed ID: 21514582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letrozole and gonadotropins versus luteal estradiol and GnRH-antagonist protocol: additional concerns.
    Wiwanitkit V
    Fertil Steril; 2011 Jun; 95(8):e78; author reply e80. PubMed ID: 21605857
    [No Abstract]   [Full Text] [Related]  

  • 5. Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization.
    Kolibianakis EM; Zikopoulos K; Smitz J; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Fertil Steril; 2004 Jul; 82(1):223-6. PubMed ID: 15237018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study.
    Stadtmauer LA; Sarhan A; Duran EH; Beydoun H; Bocca S; Pultz B; Oehninger S
    Fertil Steril; 2011 Jan; 95(1):216-20. PubMed ID: 20594551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.
    Steward RG; Gill I; Williams DB; Witz CA; Griffith J; Haddad GF
    Fertil Steril; 2011 Jan; 95(1):434-6. PubMed ID: 20810107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol.
    Griesinger G; Dawson A; Schultze-Mosgau A; Finas D; Diedrich K; Felberbaum R
    Fertil Steril; 2006 Mar; 85(3):791-3. PubMed ID: 16500366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study.
    Blockeel C; Riva A; De Vos M; Haentjens P; Devroey P
    Fertil Steril; 2011 Apr; 95(5):1714-9.e1-2. PubMed ID: 21300334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.
    Kummer NE; Weitzman VN; Benadiva CA; Schmidt DW; Engmann LL; Nulsen JC
    Fertil Steril; 2011 Jun; 95(8):2592-4. PubMed ID: 21292260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GnRH antagonist (Orgalutran) for prevention of premature LH surges during controlled ovarian hyperstimulation].
    Vladimirov Ia
    Akush Ginekol (Sofiia); 2001; 40(4):21-6. PubMed ID: 11803865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix.
    Bahceci M; Ulug U; Tosun S; Erden HF; Bayazit N
    Fertil Steril; 2006 May; 85(5):1523-5. PubMed ID: 16566935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discussion on letrozole-Gn-antagonist group needing an early start of antagonist.
    Chen X
    Fertil Steril; 2011 Jun; 95(8):e79; author reply e80. PubMed ID: 21605860
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of treatment results of the different treatment protocols in patients with poor ovarian response.
    Sanverdi I; Kutlu HT; Bilgic BE; Incebiyik A
    Gynecol Endocrinol; 2018 Jun; 34(6):524-527. PubMed ID: 29258385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose.
    Ponzano A; Colangelo EC; Di Biase L; Romani F; Tiboni GM
    Gynecol Endocrinol; 2017 Mar; 33(3):208-211. PubMed ID: 27922279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH antagonist does not prevent premature luteinization and ovulation in stimulated cycles with gonadotropins for IVF: two case reports.
    Inaudi P; Barra V; Vellucci FL; Regini C; Luisi S
    Gynecol Endocrinol; 2018 Mar; 34(3):189-191. PubMed ID: 28942696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.